Emma Boswell Dean

Health economist & assistant professor @DartmouthInst

[NIHCM @NIHCMfoundation]

Congratulations to Josh Feng, Emma Dean, and Luca Maini on being selected for the 2025 cohort of #NIHCM Research Grantees!

Read more in the release: https://t.co/h3Vy1cluiB | #NIHCMGrants2025

[The Dartmouth Institute @DartmouthInst]

Dartmouth College invites applications for the Paul Batalden Distinguished Chair in Healthcare Improvement, an endowed tenured professorship at The Dartmouth Institute for Health Policy & Clinical Practice at the Geisel School of Medicine. https://t.co/I69fCQtlyl

[Carrie H. Colla @CHColla]

Interested in health policy and economics? Check out this research project manager opening in our @DartmouthInst lab, supporting health policy and economics research. And please spread the word! https://t.co/nC38usBOyl

[Emma Boswell Dean @emmabdean]

Come work with us at @DartmouthInst ! We're hiring a programmer/analyst looking to work with medical claims datasets - let me know if I can answer any questions about the position.

[Carrie H. Colla @CHColla]

Join our fantastic team at @DartmouthInst - we're hiring! If you are a programmer/analyst and interested in working with large health care datasets, this position is a great fit: https://t.co/g9ff3X5jp6

[Emma Boswell Dean @emmabdean]

Excited to join this #DigitalHealthTech Zoom mixer! Thanks for organizing @LucyXiaolu_Wang and @NdwandweSiyab

[Lucy Xiaolu Wang @LucyXiaolu_Wang]

Join the #DigitalHealthTech ECR Zoom mixer by IHEA (@healtheconomics)⏰9/19 11am-12pm EST. Scholars w origin/geo-focus 🇺🇸🇨🇳🇭🇰🇩🇪🇬🇧🇪🇺🇷🇼🌐(4 continents+)! @zhang_zhang02 @AlexWellsjo @ThomasSchaper @AnnKreyer #EvoraHZhu @emmabdean @Wuxiaoshanshan
Register at https://t.co/FcsJrcglvE

[Lucy Xiaolu Wang @LucyXiaolu_Wang]

🚀Calling all ECRs! Join us for the ECR Zoom mixer on #DigitalHealthTech by IHEA (@healtheconomics) DHT SIG🗓️2024.9.19, 11am-12pm EST. Submit title/abstract by 8.16⌛️. @NdwandweSiyab and I will co-organize.
🔗 https://t.co/ooBMKFmSgc
#DigitalHealth #ECR #HealthEcon #EconTwitter

[Ben Hyman @ReviseNRetweet]

Very excited to finally share our draft “Wage Insurance for Displaced Workers” w/ Brian Kovak & Adam Leive, on the effects of a novel US social insurance program targeting workers displaced by structural economic shocks---wage insurance (WI). Link: https://t.co/cJPQHIv0UE /1

[Ambar La Forgia @ambarlaforgia]

Are you interested in chain organizations, acquisitions, knowledge transfer, private equity, or IVF/fertility? Then check out the updated version of my paper joint w/ @julia_bodner
https://t.co/5SaQ9HgoYP

TLDR: Chains increase IVF volume and live birth rates! Thread below.

[Josh Feng @joshfeng89]

Thread on a recently published article:
How much is prescription drug demand dependent on previous choices? What are the implications for health and firm strategy? (1/10)
https://t.co/fOkQ3Y6AzT

[UMiami Health System @UMiamiHealth]

Join our next #UMiamiHealthTalk to explore the Disruptors of the Obesity Epidemic with a panel of medical, pharmaceutical & business experts. This free webinar will be hosted by award-winning journalist & television personality, Ileana Bravo! Register here:https://t.co/uvLHba7KO8

[Rachel Werner @rm_werner]

Limiting access to CMS data is not just an academic concern. It will affect anyone enrolled in Medicare/Medicaid as well as the taxpayers who fund these programs.

Read more in my @statnews piece below and please retweet to spread the word. We have work to do!

[Sebastian Tello-Trillo @dsebastiantello]

Would love help amplifying this call: @nberpubs with support from the @NIHAging, is launching a mentoring program for PhD students who are curious about topics of health & aging or students who are already interested and want to dive deeper and develop their ideas.

[Luca Maini @luca_maini]

JOB ALERT! @timothyjlayton and I are looking to hire a full-time research assistant at @HMSHCP to work on projects related to health economics and the pharmaceutical market.

Start date this summer! More info here: https://t.co/dEYOkpocC1

@econ_ra

[Amanda Chuan @amanda_chuan]

So great to see @emmabdean at #APPAM2023. It took 10 years btwn grad school and AP, but we FINALLY managed to be at the same conference!

[Emma Boswell Dean @emmabdean]

How can exclusions of prescription drugs in commercial insurance formularies affect which drugs Medicare beneficiaries receive? Our new working paper (with the amazing @luca_maini and @joshfeng89) explains. Cliff notes version in @luca_maini's thread👇

[Luca Maini @luca_maini]

New draft out! "Stocking Under the Influence: Spillovers from Commercial Drug Coverage to Medicare Utilization" with @emmabdean (who deserves the lion's share of the credit) and @joshfeng89
https://t.co/sI5TzaUFP4
Thread below 👇

[Lucy Xiaolu Wang @LucyXiaolu_Wang]

Thrilled to co-host this year's Patent PDW with @SinaKhS at @AOMConnect in Boston! Come and learn from leading econ/mgnt scholars in #Patent/#Innovation with rich and diverse international perspectives! 🇩🇪🇮🇹🇸🇬🇺🇸 💡🤝🙌

[Emma Boswell Dean @emmabdean]

Very proud of my brilliant friend and coauthor @LucyXiaolu_Wang for winning the Adam Wagstaff award!

[Lucy Xiaolu Wang @LucyXiaolu_Wang]

Thank you, IHEA (@healtheconomics), for the #AdamWagstaffAward for "Outstanding Research on the Economics of Healthcare Financing and Delivery in LMIC" & for an awesome conference in Cape Town!🙏#IHEA2023Congress #EconTwitter @SBS_UMass @resec_umass @mpi_inno_comp @HealthEcon_CU

[Health Affairs @Health_Affairs]

In their new paper, Amelia Bond from @Cornell and coauthors analyze the administration of two high-volume biologics versus that of their biosimilar competitors. They estimate that 340B program eligibility is associated with a 66% reduction in biosimilar use relative to the mean.

[Emma Boswell Dean @emmabdean]

Congratulations @amy_m_bond and team!

[WCM Office of the Research Dean @WCMResearch]

Dr. Amelia Bond of @WCMPopHealthSci received a $1.6M grant from @AHRQNews for a study entitled “Health Systems and High-Need Populations: The Effect of Vertical Integration on Utilization, Spending, and Quality for Medically Complex Patients.”